HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

3- (((3- carboxycyclohexyl)amino)carbonyl)- 4- (3- (4- (4- (cyclohexyloxy)butoxy)phenyl)propoxy)benzoic acid

a cysteinyl leukotriene 2 (CysLT2) receptor antagonist; structure in first source
Also Known As:
HAMI 3379; HAMI-3379; HAMI3379
Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Xu, Dong-Min: 2 articles (08/2013 - 11/2012)
2. Lu, Yun-Bi: 2 articles (08/2013 - 11/2012)
3. Yu, Shu-Ying: 2 articles (08/2013 - 11/2012)
4. Wang, Xiao-Rong: 2 articles (08/2013 - 11/2012)
5. Zhang, Xia-Yan: 2 articles (08/2013 - 11/2012)
6. Shi, Qiao-Juan: 2 articles (08/2013 - 11/2012)
7. Wei, Er-Qing: 2 articles (08/2013 - 11/2012)
8. Fang, San-Hua: 2 articles (08/2013 - 11/2012)
9. Zhang, Wei-Ping: 2 articles (08/2013 - 11/2012)
10. Wei, E Q: 1 article (04/2015)

Related Diseases

1. Brain Ischemia (Cerebral Ischemia)
2. Brain Injuries (Brain Injury)
3. Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
4. Ischemia
5. Inflammation

Related Drugs and Biologics

1. cysteinyl leukotriene receptor 2
2. Immunoglobulin G (IgG)
3. Dihydrotachysterol (AT 10)